A nationwide charge comparison of the principal treatments for early stage prostate carcinoma

Cancer

Volumn 89, Issue 8, 2000, Pages 1792-1799

  Brandeis, Judson ^a   Pashos, Chris L ^b   Henning, James M ^c   Litwin, Mark S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ABT ASSOCIATES   (United States)

^c TAP Holdings Limited   (United States)

Author keywords

Charges; Costs; Prostate carcinoma; Resource utilization

Indexed keywords

AGED; ARTICLE; BRACHYTHERAPY; CANCER STAGING; CANCER THERAPY; DEMOGRAPHY; EARLY DIAGNOSIS; GEOGRAPHY; HEALTH CARE FINANCING; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; SURVIVAL RATE;

AGE FACTORS; AGED; AGED, 80 AND OVER; BENCHMARKING; BRACHYTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; COST OF ILLNESS; FEES, MEDICAL; HEALTH CARE COSTS; HOSPITAL CHARGES; HUMAN; MALE; MEDICARE; MIDDLE AGE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RACIAL STOCKS; UNITED STATES;

EID: 0034667588     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20001015)89:8<1792::AID-CNCR20>3.0.CO;2-4     Document Type: Article

References (22)

1. Prostate Cancer Clinical Guidelines Panel Summary report on the management of clinically localized prostate cancer. The American Urological Association
2. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer
3. Prostate cancer trends 1973-1995, SEER Program, National Cancer Institute
4. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Outcomes Research Team
5. Use of radical prostatectomy among Medicare beneficiaries before and after the introduction of prostate specific antigen testing
6. Internal validation of Medicare claims data
7. The impact of co-morbidity on life expectancy among men with localized prostate cancer
8. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
9. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
10. Changing trends in U.S. prostate cancer incidence rates
11. Average charges for a radical prostatectomy and a transurethral resection of the prostate (TURP): Geographic variations, 1994
12. Why do sicker patients cost more? A charge-based analysis of patients undergoing prostatectomy
13. The role of the physician in effecting change in hospital charge for radical prostatectomy
14. Prospective development of a cost-efficient program for radical retropubic prostatectomy
15. Clinical outcomes associated with the implementation of a cost-efficient programme for radical retropubic prostatectomy
16. Cost benefit of emerging technology in localized carcinoma of the prostate
17. A comparison of the costs of various treatment methods for early cancer of the prostate
18. Charge and length of hospital stay analysis of radical retropubic prostatectomy and transperineal prostate brachytherapy
19. Costing medical care: Using Medicare administrative data
20. Using Medicare claims for outcomes research
21. Maintaining quality of care and patient satisfaction with radical prostatectomy in the era of cost containment
22. Overnight hospitalization after radical prostatectomy: The impact of two clinical pathways on patient satisfaction, length of hospitalization, and morbidity